|
TW201305174A
|
|
Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives
|
|
CN103314010A
|
|
Solid phase synthesis of h(gly2)glp-2
|
|
WO2011023696A1
|
|
Methylpyrrolopyridinecarboxamides
|
|
MX2012002432A
|
|
Methylpyrrolopyrimidinecarboxamides.
|
|
WO2011015523A1
|
|
Benzyl-substituted tetracyclic heterocyclic compounds
|
|
WO2010069979A1
|
|
Pyran derivatives as ccr3 modulators
|
|
BRPI0921335A2
|
|
pyrazolone derivatives and their use as pd4 inhibitors
|
|
WO2010015585A1
|
|
6-benzyl-2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds
|
|
WO2010015588A1
|
|
Benzyl-substituted tetracyclic heterocyclic compounds
|
|
WO2010015587A1
|
|
5-benzyl-1,2,3,6-tetrahydro-4,6-diaza-cyclopenta[c]fluorene compounds and 5-benzyl-1,2,3,6-tetrahydro-4,6-diaza-cyclohepta[c]fluorene compounds
|
|
WO2010015589A1
|
|
Benzyl-substituted tetracyclic heterocyclic compounds as pde5 inhibitors
|
|
EP2321627A1
|
|
Filtering device, method for filtering of a fluid, and use of the filtering device
|
|
WO2009109525A1
|
|
Use of a specific pde4 inhibitor for the treatment and/or prophylaxis of non-alcoholic fatty liver disease
|
|
NZ586486A
|
|
Pyrrolopyrimidinecarboxamides
|
|
WO2008151927A2
|
|
6-n-substituted benz imidazole derivatives as acid pump antagonists
|
|
BRPI0811214A2
|
|
Pirazolone derivatives
|
|
WO2008074858A1
|
|
Intermediates and process for the production of 5-substituted tricyclic benzimidazoles
|
|
WO2008071765A1
|
|
Pharmaceutically active spiro-substituted benzimidazole derivatives
|
|
US2008146610A1
|
|
Isotopically substituted proton pump inhibitors
|
|
WO2008058990A1
|
|
7,7-disubstituted pyrano-[2,3-c]-imidazo-[1,2-a]-pyridine derivatives and their use as gastric acid secretion inhibitors
|
